Ryan Specialty Holdings Inc. (RYAN)
(Real Time Quote from BATS)
$51.07 USD
0.00 (0.00%)
Updated Apr 24, 2024 11:52 AM ET
2-Buy of 5 2
F Value B Growth D Momentum C VGM
Income Statements
Fiscal Year end for Ryan Specialty Holdings Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,078 | 1,725 | 1,433 | 1,018 | 765 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 2,078 | 1,725 | 1,433 | 1,018 | 765 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,718 | 1,436 | 1,246 | 860 | 664 |
Income After Depreciation & Amortization | 359 | 290 | 187 | 159 | 101 |
Non-Operating Income | -2 | -5 | -46 | -32 | 2 |
Interest Expense | 120 | 105 | 79 | 47 | 36 |
Pretax Income | 238 | 179 | 62 | 79 | 68 |
Income Taxes | 43 | 16 | 5 | 9 | 5 |
Minority Interest | 133 | 102 | -9 | 2 | -1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 194 | 163 | 57 | 71 | 63 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 61 | 61 | 66 | 68 | 64 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 494 | 415 | 311 | 231 | 156 |
Depreciation & Amortization (Cash Flow) | 135 | 126 | 124 | 73 | 55 |
Income After Depreciation & Amortization | 359 | 290 | 187 | 159 | 101 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 374.00 | 286.42 | 105.73 | NA | NA |
Diluted EPS Before Non-Recurring Items | 1.38 | 1.15 | 1.08 | NA | NA |
Diluted Net EPS (GAAP) | 0.52 | 0.52 | -0.07 | NA | NA |
Fiscal Year end for Ryan Specialty Holdings Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 532.86 | 501.94 | 585.15 | 457.60 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 532.86 | 501.94 | 585.15 | 457.60 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 436.52 | 432.12 | 462.31 | 387.52 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 96.34 | 69.82 | 122.84 | 70.08 |
Non-Operating Income | NA | -7.49 | 2.20 | 1.51 | 2.13 |
Interest Expense | NA | 29.67 | 31.49 | 28.88 | 29.47 |
Pretax Income | NA | 59.18 | 40.53 | 95.47 | 42.75 |
Income Taxes | NA | 0.67 | 24.83 | 11.65 | 6.30 |
Minority Interest | NA | 35.66 | 20.75 | 53.74 | 23.30 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 58.50 | 15.70 | 83.82 | 36.46 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 22.85 | -5.05 | 30.08 | 13.16 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 325.02 | 115.87 | 322.37 | 266.98 |
Diluted EPS Before Non-Recurring Items | NA | 0.35 | 0.32 | 0.45 | 0.26 |
Diluted Net EPS (GAAP) | NA | 0.19 | -0.04 | 0.26 | 0.11 |